Literature DB >> 5694750

Mitomycin C therapy in advanced gastrointestinal cancer.

C G Moertel, R J Reitemeier, R G Hahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5694750

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

Review 1.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 2.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

3.  Modulation of mitomycin C-induced multidrug resistance in vitro.

Authors:  R T Dorr; J D Liddil
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Mitomycin C: experience in the United States, with emphasis on gastric cancer.

Authors:  P S Schein; J S Macdonald; D Hoth; P V Wooley
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 5.  Acute liver injury.

Authors:  I C Talbot
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

6.  Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

7.  Effect of selective inhibition of aquaporin 1 on chemotherapy sensitivity of J82 human bladder cancer cells.

Authors:  Xuefeng Zhang; Yun Chen; Liming Dong; Benkang Shi
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

8.  Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer.

Authors:  E A Poplin; P LoRusso; J J Lokich; J J Gullo; P D Leming; J J Schulz; S R Veach; W McCulloch; L Baker; P Schein
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.

Authors:  S S Pan; S A Akman; G L Forrest; C Hipsher; R Johnson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Improved combination chemotherapy in advanced gastric cancer.

Authors:  J A Levi; D N Dalley; R S Aroney
Journal:  Br Med J       Date:  1979-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.